Drugs that contain Dexmethylphenidate Hydrochloride
1. Focalin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6355656 | SANDOZ | Phenidate drug formulations having diminished abuse potential |
Dec, 2015
(8 years ago) | |
| US6528530 | SANDOZ | Phenidate drug formulations having diminished abuse potential |
Dec, 2015
(8 years ago) | |
| US5908850 | SANDOZ | Method of treating attention deficit disorders with d-threo methylphenidate |
Dec, 2015
(8 years ago) | |
Market Authorisation Date: 13 November, 2001
Treatment: Method of treating at least one of attention deficit disorder and attention deficit hyperactivity disorder
Dosage: TABLET;ORAL
How can I launch a generic of FOCALIN before it's drug patent expiration?
More Information on Dosage
FOCALIN family patents
2. Focalin Xr patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5837284 | SANDOZ | Delivery of multiple doses of medications |
Dec, 2015
(8 years ago) | |
| US5908850 | SANDOZ | Method of treating attention deficit disorders with d-threo methylphenidate |
Dec, 2015
(8 years ago) | |
| US7431944 | SANDOZ | Delivery of multiple doses of medications |
Dec, 2015
(8 years ago) | |
| US6355656 | SANDOZ | Phenidate drug formulations having diminished abuse potential |
Dec, 2015
(8 years ago) | |
| US6528530 | SANDOZ | Phenidate drug formulations having diminished abuse potential |
Dec, 2015
(8 years ago) | |
| US6635284 | SANDOZ | Delivery of multiple doses of medications |
Dec, 2015
(8 years ago) | |
| US6228398 | SANDOZ | Multiparticulate modified release composition |
Nov, 2019
(4 years ago) | |
| US6730325 | SANDOZ | Multiparticulate modified release composition |
Nov, 2019
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-80) | Oct 17, 2011 |
| New Dosing Schedule(D-121) | Oct 23, 2012 |
Market Authorisation Date: 26 May, 2005
Treatment: Method of treating attention deficit disorder and/or attention deficit hyperactivity disorder; A method of treating disease amenable to treatment with a phenidate drug by once daily oral administratio...
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of FOCALIN XR before it's drug patent expiration?
More Information on Dosage
FOCALIN XR family patents